ATOS - Atossa Genetics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--1.758
Cost of Revenue--132.411
Gross Profit---130.653
Operating Expenses
Research Development2,328.087770.4272,359.593
Selling General and Administrative4,859.3696,479.19310,268.372
Non Recurring461.715718.97718.97
Total Operating Expenses---
Operating Income or Loss-7,649.171-7,968.59-12,758.618
Income from Continuing Operations
Total Other Income/Expenses Net-473.411,599.7050.431
Earnings Before Interest and Taxes-8,122.581-6,368.885-12,758.187
Interest Expense---
Income Before Tax-8,122.581-6,368.885-12,758.187
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-8,122.581-6,368.885-12,758.187
Non-recurring Events
Discontinued Operations---3,002.136
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-8,122.581-6,368.885-15,760.323
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,690.713-6,368.885-15,760.323